Nuvation Bio Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Nuvation Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • Nuvation Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.57M, a 73.3% increase year-over-year.
  • Nuvation Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $23.8M, a 29.9% increase year-over-year.
  • Nuvation Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.5M, a 19.8% increase from 2022.
  • Nuvation Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.3M, a 75.8% increase from 2021.
  • Nuvation Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.27M, a 321% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $23.8M $9.57M +$4.05M +73.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $19.7M $5.04M +$204K +4.22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $19.5M $3.72M -$1.27M -25.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $20.8M $5.43M +$2.49M +84.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $18.3M $5.52M +$736K +15.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $17.6M $4.84M +$1.26M +35.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $16.3M $4.99M +$2.19M +78.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $14.1M $2.94M +$191K +6.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $13.9M $4.79M +$2.63M +122% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $11.3M $3.58M +$2.01M +128% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $9.27M $2.8M +$1.68M +149% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $7.59M $2.75M +$2.4M +690% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $5.19M $2.15M +$1.76M +453% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.43M $1.57M +$1.23M +361% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $2.2M $1.13M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $348K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $389K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $340K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.